2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$0.87+$0.006 (+0.69%)
Price as of Oct 02, 2026 7:55 PM EDT- $12.8MMarket Cap
- -79.07%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$0.87+$0.006 (+0.69%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.86 | ||
Change | -$0.14 (-13.99%) | ||
Open | $1.03 | ||
High | $1.04 | ||
Low | $0.84 | ||
Previous Close | $1.00 | ||
Volume | 433,629 | ||
30-Day Average Volume | 284,955 | ||
1-Week Change | -29.50% | ||
1-Month Change | -55.44% | ||
1-Year Change | -79.07% | ||
3-Year Change | -73.78% | ||
5-Year Change | -91.96% | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $8.6M | ||
Market Cap | $12.8M | ||
Enterprise Value | $6.1M | ||
Period: QTR TTM FY | |||
Revenue | $27,238.00 | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$7.1M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $4.1M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 225 | ||
P/B | N/A | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue